Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 925.00 | 1102.75 | 0.8388 | 0.8459 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2542.00 | 2605.75 | 0.9755 | 0.9788 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 1250.00 | 520.59 | 860.00 | 2605.75 | 0.3300 | 0.2412 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 2539.00 | 2605.75 | 0.9744 | 0.9778 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 2407.00 | 2605.75 | 0.9237 | 0.9329 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2606.00 | 2605.75 | 1.0001 | 1.0001 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 1250.00 | 520.59 | 1495.00 | 2605.75 | 0.5737 | 0.5746 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 3006.00 | 2605.75 | 1.1536 | 1.1269 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 3075.00 | 2605.75 | 1.1801 | 1.1477 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 1250.00 | 520.59 | 3144.00 | 2605.75 | 1.2066 | 1.1683 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2968.00 | 2605.75 | 1.1390 | 1.1152 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 1250.00 | 520.59 | 2574.00 | 2605.75 | 0.9878 | 0.9895 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 1250.00 | 520.59 | 1746.00 | 2605.75 | 0.6701 | 0.6834 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 3030.00 | 2605.75 | 1.1628 | 1.1341 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 1250.00 | 520.59 | 627.00 | 2605.75 | 0.2406 | 0.0833 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 2616.00 | 2605.75 | 1.0039 | 1.0034 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2936.00 | 2605.75 | 1.1267 | 1.1054 | |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 1250.00 | 520.59 | 1883.00 | 2605.75 | 0.7226 | 0.7390 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 1250.00 | 520.59 | 1084.00 | 2605.75 | 0.4160 | 0.3712 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2905.00 | 2605.75 | 1.1148 | 1.0958 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2803.00 | 2605.75 | 1.0757 | 1.0638 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2278.00 | 2605.75 | 0.8742 | 0.8876 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2250.00 | 2605.75 | 0.8635 | 0.8776 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2454.00 | 2605.75 | 0.9418 | 0.9490 | |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 1250.00 | 520.59 | 2770.00 | 2605.75 | 1.0630 | 1.0533 |